| # | Drug | Count |
|---|---|---|
| 0 | PREGABALIN | 10 |
| 1 | OMEPRAZOLE | 9 |
| 2 | OMEPRAZOLE MAGNESIUM | 9 |
| 3 | PREDNISONE | 9 |
| 4 | CISPLATIN | 7 |
| 5 | INSULIN GLARGINE | 7 |
| 6 | ROSUVASTATIN | 7 |
| 7 | ALFUZOSIN HYDROCHLORIDE | 6 |
| 8 | ATOVAQUONE | 6 |
| 9 | ATOVAQUONE ORAL SUSPENSION | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TECLISTAMAB-CQYV | 6 | 0.0025 |
| 1 | ALFUZOSIN HYDROCHLORIDE | 6 | 0.0024 |
| 2 | SODIUM HYALURONATE | 1 | 0.0012 |
| 3 | FECAL MICROBIOTA SPORES, LIVE-BRPK | 1 | 0.0008 |
| 4 | ATOVAQUONE | 6 | 0.0007 |
| 5 | APREPITANT | 4 | 0.0005 |
| 6 | MARIBAVIR | 1 | 0.0004 |
| 7 | AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL | 1 | 0.0004 |
| 8 | FOSAPREPITANT DIMEGLUMINE | 4 | 0.0003 |
| 9 | CLINDAMYCIN PHOSPHATE TOPICAL | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 16 |
| 1 | Corticosteroid [EPC] | 15 |
| 2 | Platinum-based Drug [EPC] | 13 |
| 3 | Insulin Analog [EPC] | 7 |
| 4 | Antimalarial [EPC] | 6 |
| 5 | Antiprotozoal [EPC] | 6 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 6 |
| 7 | Alkylating Drug [EPC] | 5 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 9 | Human Immunoglobulin G [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimalarial [EPC] | 6 | 0.0006 |
| 1 | Antiprotozoal [EPC] | 6 | 0.0006 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 3 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 5 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 6 | Standardized Insect Venom Allergenic Extract [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 2 | 0.0001 |
| 9 | Non-Standardized Plant Allergenic Extract [EPC] | 1 | 0.0001 |